Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

JPMorgan Raises Merck Price Target to $150 Amid Ongoing Tech Sector Review

Guavy AI Editorial Team
Instruments
JPM MRK
Share

JPMorgan has revised its price target for Merck & Co. to $150 from $140, maintaining its Overweight rating on the pharmaceutical giant.

The move comes as part of JPMorgan's broader analysis of leading tech companies, which it deems 'influential in their industries' and 'notable for robust innovation and profitability.'

Merck & Co. is one of several Featured Tech Stocks that JPMorgan has identified as market leaders with significant economic impact.

More on Stocks

Stocks just now

Disney's Asteria Community Unveils Entrancing Entryway in North Carolina

Stocks just now

Disney CEO Congratulates Sony on Spider-Man: Brand New Day Success

Stocks just now

Disney's Summer Blockbuster Season Falls Short

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy